Table 1.
Non-autistic participants | Autistic participants | ||||||
---|---|---|---|---|---|---|---|
Range | M | SD | Range | M | SD | p value | |
Age | 12.1–16.9 | 14.4 | 1.4 | 12.5–16.9 | 14.8 | 1.0 | 0.21 |
IQ | 80–135 | 111 | 12 | 80–132.5 | 107.5 | 12.6 | 0.24 |
AQ | 2–22 | 8.4 | 5.0 | 3–22 | 12.9 | 4.7 | <0.001 a |
DIF | 7–17 | 10.5 | 2.5 | 7–17 | 11.8 | 2.9 | 0.03 a |
DDF | 5–15 | 9.0 | 2.9 | 5–15 | 10.0 | 2.5 | 0.14 |
Motion during scan | 0.05–0.26 | 0.099 | 0.048 | 0.05–0.18 | 0.080 | 0.027 | 0.046 a |
n | % | n | % | ||||
Medication use | 0 | 100 | 15 | 42.9 | |||
Methylphenidate | 12 | 34.3 | |||||
Antipsychotics | 4 | 11.4 | |||||
Other | 5 | 14.3 | |||||
Comorbidities | 0 | 100 | 20 | 57.1 | |||
Dyslexia | 9 | 25.7 | |||||
ADHD | 8 | 22.9 | |||||
PTSD | 2 | 5.7 | |||||
Sensory integration disorder | 2 | 5.7 | |||||
Other | 4 | 11.4 | |||||
Ethnicity | |||||||
The Netherlands | 31 | 91.2 | 33 | 94.3 | |||
Western Europe | 0 | 0 | 1 | 2.9 | |||
South Africa | 1 | 2.9 | 1 | 2.9 | |||
USA | 1 | 2.9 | |||||
Southeast Asia | 1 | 2.9 | |||||
Gross annual income | |||||||
<€31.000– | 2 | 5.9 | 3 | 8.6 | |||
€31.000–€76.000 | 18 | 53 | 16 | 45.7 | |||
>€76.000– | 13 | 38.2 | 10 | 28.6 | |||
Declined to disclose | 1 | 2.9 | 6 | 17.1 |
IQ: estimated based on 2 WISC/WAIS-III subtests: block patterns and similarities; AQ: autism quotient questionnaire measuring autism traits; DIF: alexithymia difficulty identifying feelings; DDF: alexithymia difficulty describing feelings; SD: standard deviation; ADHD: attention-deficit/hyperactivity disorder; PTSD: post traumatic stress disorder.
Independent samples t test indicates significant difference between groups.